1. Introduction {#sec1}
===============

Stroke, an acute cerebrovascular event caused by brain arterial or venous thrombosis or intracerebral hemorrhage, presents a variety of clinical syndromes such as facial paralysis, skewed mouth, slurred speech, or paralysis \[[@B1]\]. The death would happen without timely diagnosis and treatment or serious disability left over due to a large infarct/hemorrhage area. According to a study of the global burden of disease in 2016, the results showed that stroke has been the second cause of mortality and there are 80.1 million stroke patients worldwide, of which approximately 84.4% are ischemic stroke \[[@B2]\]. However, stroke has been the leading cause of premature death in China \[[@B3]\] and causes a serious social burden which may still increase as the persistent aging population and lack of attention to high-risk factors \[[@B4]\]. Currently, clinical therapy includes intravenous thrombolysis, endovascular therapy, antiplatelet aggregation, and other types of management of high-risk factors. Yet, for all this, the mortality has generally declined, and disability and recurrence rates remain high \[[@B2]\], which causes the occurrence of alternative and complementary therapy \[[@B5]\]. Therefore, it is critical to seek more effective measures to prevent and treat stroke.

Chinese herbal medicine has treated stroke for a long time and could provide a rosy prospect for stroke because of rich drugs and prescription resources \[[@B6], [@B7]\]. Musk (scientific name: *Moschus*, Chinese pinyin: Shexiang) was first set out in *Shen Nong\'s Materia Medica* and could treat stroke because of the effect of inducing resuscitation, activating blood, dissipating stagnation, and alleviating pain \[[@B8]\]. *The Guide* recorded that musk could clear orifices from our muscles into the bone marrow.*Compendium of Materia* Medica says that it can open contained orifices, channels, and collaterals \[[@B9], [@B10]\]. Preclinical studies revealed that musk can improve the behavior score and the volume of cerebral infarction in rats with transient local cerebral ischemia-reperfusion injury \[[@B11]\] and showed that muscone could play a neuroprotective role by downregulation of the expression of glutamate transporter and suppression of its reverse transport \[[@B12]\]. Therefore, the extraction of musk has been recommended and listed in China and pharmacopeia for cardiovascular and cerebrovascular disease \[[@B13]\]. However, the mechanism of musk for ischemic stroke was unclear, lacking systematic experiments. So, it is momentous to explore the effective mechanism of musk for ischemic stroke with multiple components, multiple targets, and multiple pathways.

Hopkins first set out that "network pharmacology has become a new scientific method that combined biology, pharmacology, bioinformatics, and computer technology to systematically study the effective mechanisms of multicomponent and multitarget drugs" \[[@B14]\]. This method of analyzing the drug effect mechanism from the network level is an effective supplement to the previous model of reductionist drug development. Chinese medicine has the characteristics of multiple components, multiple targets, and multiple pathways, which is consistent with the research ideas and methods of network pharmacology \[[@B15]\]. This study aimed to use this novel way to predict the musk target, construct the protein-protein interaction (PPI) network, screen topology, and do the gene function analysis. So, based on this approach, it could reveal the mechanisms of musk in treating ischemic stroke to provide evidence of pharmacological experiments and clinical application.

2. Materials and Methods {#sec2}
========================

Network pharmacology mainly includes data acquisition and network analysis. The data obtained includes active ingredients of traditional Chinese medicine, a target of component action, and a target of disease-related genes. Based on the data obtained, network analysis constructs and analyzes the interaction between the nodes of the network, the network topology characteristics, and the identification of biological processes and signal pathways affected by the target, thereby clarifying the mechanism of action of traditional Chinese medicine. The following is the role of the database used in the study, as well as the flow chart (see Figures [1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"} for details).

2.1. Recognizing Compounds of Musk and Predicting Functional Targets {#sec2.1}
--------------------------------------------------------------------

In this study, the BATMAN-TCM analytical platform was used to obtain the composition of musk and to predict the target of the composition. BATMAN-TCM is an online analysis platform for the Molecular Mechanism of Traditional Chinese Medicine. It mainly performs target prediction, target gene function analysis, pathway enrichment analysis, and multitraditional Chinese medicine comparative analysis \[[@B16]\]. It uses a similarity-based method to predict potential targets of herb\'s ingredients. The principle of this method is to rank all candidate targets according to the prediction score given by the target prediction algorithm for the drug-target interaction prediction, and the targets with higher scores are regarded as potential drug targets \[[@B17]\]. If the score of a predicted target is greater than or equal to the "Score cutoff," then this target will be regarded as a potential target of the investigated component. So, in the BATMAN-TCM platform "Cluster name," we input the Pinyin "SHE XIANG" of musk and set the "Score cutoff" value to 20 and adjusted the *P* value which was set at 0.05 to predict the potential target of musk. Then, we used the UniProt (<https://www.uniprot.org/>) database to search for the predicted target, selected the species as "Homo sapiens," and excluded nonhuman sources and nonstandard targets. Finally, the relevant targets of musk active ingredients were obtained.

2.2. Obtaining Ischemic Stroke-Associated Targets {#sec2.2}
-------------------------------------------------

Ischemic stroke-related targets are collected from the following six disease-related databases: (1) DisGeNET (<http://www.disgenet.org>) \[[@B18]\], (2) NCBI-Gene (<https://www.ncbi.nlm.nih.gov/gene/>), (3) Human Phenotype Ontology (HPO) (<https://hpo.jax.org/app/>) \[[@B19]\], (4) Online Mendelian Inheritance in Man (OMIM) (<https://www.omim.org/>) \[[@B20]\], (5) DrugBank (<https://www.drugbank.ca/>) \[[@B21]\], and (6) Therapeutic Target Database (TDD) (<http://bidd.nus.edu.sg/group/cjttd/>) \[[@B22]\]. In these databases, we use the keywords "ischemic stroke," "brain ischemia," "cerebral infusion," and "cerebral ischemia" as queries to search for known targets associated with ischemic stroke and to remove duplicate genes.

2.3. Protein-Protein Interaction (PPI) Network Construction {#sec2.3}
-----------------------------------------------------------

String (<https://String-db.org/>) database is a database used to search for protein interactions. It contains a large number of known or predicted protein-protein interactions, including both direct physical interactions and indirect functional relationships \[[@B23]\]. Targets of musk and ischemic stroke were introduced into the String database, and the species was defined as "Homo Sapiens." The target PPIs of musk and ischemic stroke were constructed. Drawing Venn diagrams is applied online at the intersection of LZTB targets obtained via BATMAN-TCM and Ra targets obtained by DisGeNET. According to the intersection of PPI data, after merging these two networks into candidate networks, the core PPI networks are screened by analyzing the topological characteristics. Venny 2.1.0 (<http://bioinfogp.cnb.csic.es/tools/Venny/index.html>) was used to analyze the intersection of musk component target and ischemic stroke target PPI. Based on the results of the PPI network intersection, the candidate PPI network was determined, and the target core PPI network of musk-ischemic stroke was further screened through the network topology characteristics.

The following networks were constructed in this study: (1) compound-compound target network of musk, (2) compound target-ischemic stroke network, and (3) a complex network of "compound-target-pathway". All the networks were generated by employing the network visualization software Cytoscape (version: 3.6.1, <http://www.cytoscape.org/>). Cytoscape is an open-source software, which conveniently offers numerous bioinformatic analysis tools to further network analysis.

2.4. Network Topology Analysis {#sec2.4}
------------------------------

Network Centrality is a key index to measure the importance of nodes in a network, including degree, betweenness, and closeness centrality \[[@B24]\]. The higher the value of these three indexes is, the more important the node is in the network. This paper uses the "Network Analyzer" plug-in of Cytoscape 3.6.1 to analyze the candidate PPI network and obtains the topological characteristic values such as degree centrality, medium centrality, and closeness centrality. Based on the results of the "Network Analyzer," the median of degree centrality, medium centrality, and compactness centrality was used as the chi-square value, and the target of satisfying three chi-square values at the same time was selected as the core target for treating ischemic stroke.

2.5. Gene Ontology (GO) and KEGG Pathway Enrichment Analysis {#sec2.5}
------------------------------------------------------------

Gene Ontology (GO; <http://www.geneontology.org/>) provides detailed annotation of genes from cell components, molecular functions, and biological processes \[[@B25]\]. Kyoto Encyclopedia of Genes and Genomes (KEGG; <https://www.kegg.jp/>) provides integration of chemical, genomic, and systemic functional information for understanding the advanced functions and uses of biological systems at the molecular level \[[@B26]\]. The Database for Annotation, Visualization, and Integrated Discovery (DAVID; <http://www.david.niaid.nih.gov>) integrates GO, KEGG, UniProt, and DrugBank, among other authoritative data sources, to provide systematic bioinformatic annotations for large-scale genes or proteins, including annotation of biological processes and enrichment of pathways \[[@B27]\]. In this study, the core targets of musk for ischemic stroke were uploaded to the DAVID database, which analyzed their gene function and pathway enrichment. According to the *P* value, the core targets were displayed in the form of a chart.

2.6. Identifying Core Clusters of PPI Network {#sec2.6}
---------------------------------------------

In complex biological information networks, some genes or proteins are closely related and have the same or similar functions, so they can be regarded as a cluster and play an important biological role in coordination. The information of each node in the network helps us to perform cluster analysis and build functional modules \[[@B28]\]. Molecular Complex Detection (MCODE) is an automated method for finding molecular complexes in large protein interaction networks. The functional modules of the PPI network in the heart of ischemic stroke treated with musk were selected by using the MCODE analysis function integrated into the Metascape (<http://Metascape.org/>) \[[@B29]\].

3. Results {#sec3}
==========

3.1. Compounds of Musk and Target Prediction {#sec3.1}
--------------------------------------------

According to the BATMAN-TCM database, we selected the chemical composition and target information of musk with the Score cutoff value greater than 20. Among them, 29 chemical constituents of musk were obtained, including macrocyclic ketone compounds such as muscone and normuscone, steroid compounds such as androst-4-ene-3, 17-dione, muscol, and 17-beta-estradiol, and pyridine compounds such as muscopyridine and hydroxymuscopyridine a/b (for more detailed information, see [Table 1](#tab1){ref-type="table"}). In addition, using the principle of chemical structure similarity to predict the target of musk components, 1081 targets were picked up.

3.2. Disease Targets {#sec3.2}
--------------------

By means of the six databases, namely, DisGeNET, NCBI-Gene, DrugBank, HPO, OMIM, and TTD, we obtained 737, 642, 4, 67, 5, and 16 ischemic stroke-related targets. Summarizing the results of various databases and removing duplicate genes, finally, a total of 1104 ischemic stroke-related targets were picked up.

3.3. Construction of PPI Network and Analysis of Network Topological Eigenvalues {#sec3.3}
--------------------------------------------------------------------------------

In the current study, we constructed the following networks: compound-compound target network of musk, and compound target-ischemic stroke network. Furthermore, 222 common targets were identified from the above PPI network, as candidate targets (see [Figure 3](#fig3){ref-type="fig"}).

Based on the BATMAN-TCM database, a single herb, musk, was analyzed in terms of gene function, pathway enrichment, and disease phenotype. On the basis of the results, we drew a simplified association network of "ingredients-target-pathway/disease network," as shown in [Figure 4](#fig4){ref-type="fig"}. The results suggested that effective components of musk could act on the cGMP-PKG signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, MAPK signaling pathway, calcium signaling pathway, vascular smooth muscle contraction, cell cycle, etc. In the aspect of disease phenotypic enrichment, musk had strong pharmacological effects on neurological disease, cardiovascular disease, respiratory disease, mental disorders, and painful diseases.

After a topological analysis of the PPI network, we chose the target which satisfies the median of degree centrality, medium centrality, and compactness centrality, as core target in treating ischemic stroke. A total of 88 key targets were obtained. Next, we used Cytoscape 3.6.1 software to visualize the component target-disease target interaction network. Network details are shown in [Figure 5](#fig5){ref-type="fig"}. Targets with the highest degree of freedom were AKT serine/threonine kinase 1 (AKT1), mitogen-activated protein kinase 1/3 (MAPK1/3), tumor protein p53 (TP53), tumor necrosis factor (TNF), SRC proto-oncogene (SRC), Fos proto-oncogene (FOS), caspase 3 (CASP3), Jun proto-oncogene (JUN), nitric oxide synthase 3 (NOS3), and interleukin 1 beta (IL1B). These results indicated that the mechanism of musk for ischemic stroke was significantly related to those targets.

3.4. Enrichment Analysis of Core Targets {#sec3.4}
----------------------------------------

In order to understand the function and the underlying significance of core targets, we uploaded 88 core targets into the DAVID database. The result was classified into three parts: biological processes, molecular function, and cellular component. Moreover, those terms were sorted according to the *P* value (see [Table 2](#tab2){ref-type="table"}). In the biological processes, we found that they mainly concentrate on positive regulation of transcription from RNA polymerase II promoter, positive regulation of transcription, DNA-templated, aging, response to drug, positive regulation of gene expression, regulation of blood pressure, response to hypoxia, response to hypoxia, negative regulation of the apoptotic process, and so on. The molecular function was related to transcription factor binding, enzyme binding, protein binding, protein kinase binding, and transcription regulatory region DNA binding. Finally, the cellular component was mainly composed of nucleoplasm, cytosol, protein complex, plasma membrane, extracellular space, caveola, and nucleus.

According to the literature and KEGG enrichment analysis, the pharmacological effects of musk for ischemic stroke were associated with TNF signaling pathway, estrogen signaling pathway, prolactin signaling pathway, neurotrophin signaling pathway, T-cell receptor signaling pathway, cAMP signaling pathway, FoxO signaling pathway, HIF-1 signaling pathway, nonalcoholic fatty liver disease (NAFLD), Rap1 signaling pathway, and so on (the details are depicted in [Table 3](#tab3){ref-type="table"}). This indicated that active components of musk were distributed in different metabolic pathways. Multiple components and multiple targets were the possible mechanisms of musk for ischemic stroke.

3.5. Identification of Core PPI Clusters {#sec3.5}
----------------------------------------

Based on the MCODE clustering analysis, the core PPI network of musk for ischemic stroke could be divided into 4 modules ([Figure 6](#fig6){ref-type="fig"}) as follows. Cluster 1 (MCODE 1) contained 24 genes, score 5.21, and core gene was TP53; cluster 2 (MCODE 2) contained 11 genes, score 2.81, and core gene was RELA; cluster 3 (MCODE 3) contained 6 genes, score 1.17, and core gene was CRH; cluster 4 (MCODE 4) contained 4 genes, score 1.25, and core gene was CTNNB1.

KEGG enrichment analysis of cluster 1 (MCODE 1) and cluster 2 (MCODE 2) was carried out. Top 10 KEGG enrichment pathways were obtained and framed in a bubble plot according to the *P* value ([Figure 7](#fig7){ref-type="fig"}). As depicted in the figure, those genes of cluster 1 and cluster 2 were associated with the AGE-RAGE signaling pathway in diabetic complications, Th17 cell differentiation, thyroid hormone signaling pathway, prolactin signaling pathway, and B-cell receptor signaling pathway.

3.6. Multidimensional Network Analysis of "Traditional Chinese Medicine-Composition-Target-Pathway" {#sec3.6}
---------------------------------------------------------------------------------------------------

Integrating the results of network pharmacological analysis, we constructed a multidimensional network of "traditional Chinese medicine-composition-target-pathway," as shown in [Figure 8](#fig8){ref-type="fig"}. We concluded that the mechanism of musk-mediated ischemic stroke therapy was related to many genes and compounds. It possibly affected AKT1, MAPK1/3, TP53, TNF, SRC, FOS, CASP3, JUN, NOS3, and IL1B. Moreover, musk prevented ischemic stroke via numerous signaling pathways, including TNF signaling pathway, estrogen signaling pathway, prolactin signaling pathway, neurotrophin signaling pathway, T-cell receptor signaling pathway, cAMP signaling pathway, FoxO signaling pathway, and HIF-1 signaling pathway. Therefore, our research had shown that musk can treat ischemic stroke through regulating inflammation-immune response, apoptosis, signal transduction, nervous system, and circulatory system-related signal pathway.

4. Discussion {#sec4}
=============

According to TCM theory, ischemic stroke belongs to the category "apoplexy" and causes sudden faint flutter, deviation of the eye and mouth, hemiplegia, etc. Cerebral blood stasis was basic pathogenesis. Therefore, clinical treatments are mainly based on inducing resuscitation, promoting blood circulation by removing blood stasis, and the effect is significant. Chinese medicine "musk" has resuscitation, promoting blood, dissipating mass, and analgesic effect, commonly used in the treatment of ischemic stroke. Currently, basic and clinical research on musk for ischemic stroke mostly focuses on a single component or a single pharmacological effect. However, the pathophysiology of ischemic stroke is complicated. Musk plays a role in the treatment of ischemic stroke through multiple links and multiple ways, and those studies cannot fully reflect that. Studies on system biology have revealed a high degree of correlation between molecular network regulation and diseases. Especially for complex systemic diseases, the simultaneous intervention of multiple targets may achieve better efficacy and less toxic and side effects. Network pharmacology is based on the "disease-gene-target-drug" interaction network, which systematically observes the intervention and impact of drugs on disease networks, thereby revealing the mystery of the synergistic effect of drugs on the human body \[[@B30]\]. Taking ischemic stroke as an example, Casas et al. \[[@B31]\] predicted the protein metabolism network related to NOX4 target from the network pharmacological mechanism and screen core proteins by Gene Ontology analysis. Finally, in vivo and in vitro experiments verified that NOX4 and NOS inhibition is highly synergistic. By inhibiting multiple related targets at the same time, it plays a role in neuroprotection and stabilization of the blood-brain barrier. It can be seen that network pharmacology is of great significance to reveal the mechanism of multitarget drugs to treat diseases. In consequence, this study explores the potential active ingredients and effective mechanisms of musk for ischemic stroke through network pharmacological analysis, with a view to providing theoretical evidence for the development of musk as an adjuvant for ischemic stroke.

In the current study, a total of 29 ingredients including macrocyclic ketone compounds such as muscone, muscol, and normuscone, steroid compounds such as androst-4-ene-3, 17-dione, testosterone, and 17-beta-estradiol, pyridine compounds such as muscopyridine and hydroxymuscopyridine a/b were identified as potential active ingredients of musk. Some active ingredients have proved to be effective in reducing brain damage and improving neurological function after ischemic stroke. For example, muskone can inhibit the expression of Fas and caspase-8 in the cortex, thereby inhibiting apoptosis of neural cells and significantly reducing the volume of cerebral infarction \[[@B32]\]. In addition, after muskone was administered, neural stem cells proliferated actively and transformed into neurons in ischemia-reperfusion rats, which suggested the role of muskone in nerve repair after ischemic stroke \[[@B33]\]. Changes in hormone levels can affect the occurrence of cardiovascular and cerebrovascular diseases \[[@B34]\]. The lower endogenous testosterone concentration in men is associated with a risk of ischemic stroke, which is partially mediated by BMI and hypertension \[[@B35]\]. However, it is unclear whether the treatment of exogenous testosterone has cardiocerebrovascular protection, and further randomized controlled trials are needed to clarify. Moreover, 17-beta-estradiol can protect the brain from ischemic damage after stroke. Its mechanism is closely related to apoptosis, immune regulation, and antioxidative stress \[[@B36]\]. Gibson et al. found that estrogen can reduce the volume of cerebral infarction \[[@B37]\]. The above studies show the effectiveness and diversity of musk active ingredients in the treatment of ischemic stroke.

After analyzing the PPI network of musk for ischemic stroke, we found that the core targets of musk for ischemic stroke were AKT1, MAPK1/3, TP53, TNF, SRC, FOS, CASP3, JUN, NOS3, IL1B, and so on. These targets were involved in transcriptional regulation, gene regulation, apoptosis regulation, and other biological processes. And the results of our research were consistent with the published studies.

AKT is a serine/threonine protein kinase, which plays an antiapoptotic role by phosphorylating downstream target proteins \[[@B38]\]. There are 3 subtypes of AKT, namely, AKT1, AKT2, and AKT3. And AKT1 is widely expressed in tissues in vivo \[[@B39]\]. Evidence showed that AKT expression and phosphorylation increased in cerebral ischemia-reperfusion injury \[[@B40]\]. AKT has neuroprotective effects. Early activation of AKT can reduce infarct volume after cerebral ischemia-reperfusion injury and improve oxygen supply/consumption balance in local brain tissue \[[@B41]\]. According to researches, many Chinese medicine ingredients can regulate the expression of apoptosis-related proteins through AKT/autophagy, PI3K/AKT, and other pathways. In an ischemic and hypoxic environment, muscone was found to improve ischemia-reperfusion injury by activating the PI3K/AKT pathway and promoting endothelial eNOS phosphorylation \[[@B42]\]. Consequently, those ingredients improve the survival rate of nerve cells and reduce the degree of brain damage \[[@B43]--[@B45]\]. In addition, well-functioning collateral circulation improves the clinical prognosis of ischemic stroke, so, angiogenesis may be a potential direction for ischemic stroke. AKT also plays an important role in angiogenesis. It not only regulates the expression of VEGF directly but also regulates the expression of various angiogenic factors indirectly, as an upstream signal of mTOR \[[@B46], [@B47]\].

At present, MAPK signaling has been extensively studied, and it plays a pivotal role in regulating apoptosis and inflammatory cytokine expression after ischemic stroke \[[@B48]\]. In the early stage of ischemia, the expression of p38 MAPK in neurons and glial cells begins to increase \[[@B49]\]. Then, the activated p38 MAPK promotes the release of inflammatory cytokines and induces the expression of adhesion molecules on vascular endothelial cells. Thus, the blood-brain barrier is damaged, and brain damage is aggravated. On the other hand, inflammatory cytokines, in turn, can promote p38 MAPK activation. In the end, it leads to a vicious cycle and exacerbates the cascade of inflammation \[[@B50]\]. MAPK1 (ERK2), MAPK3 (ERK1), and p38 MAPK have high homology. In ischemic stroke, they participate in the regulation of proinflammatory cytokines such as IL-1*β* and TNF-*α* by activating the MAPK cascade \[[@B51]\]. Therefore, by inhibiting the signal transduction of MAPK, it has potential therapeutic prospects for reducing the inflammatory response and blood-brain barrier destruction after ischemic stroke.

Furthermore, TP53 is a tumor suppressor gene, which is associated with the regulation of cell cycle and apoptosis. When an ischemic stroke occurs, the brain is in ischemia and hypoxic environment, which makes the cells in a stress state, and DNA homeostasis is destroyed \[[@B52]\]. Then, TP53-mediated apoptosis was launched. Gomez-Sanchez reports that TP53 Arg/Arg genotype controls the vulnerability of neuronal apoptosis and is a genetic marker for predicting adverse functional outcomes after stroke \[[@B53]\]. TNF is one of the important inflammatory cytokines, with an effect of microglia activation, promoting adhesion and chemokine expression \[[@B54]\]. It is one of the key causes of nerve cell damage after ischemic stroke. Moreover, SRC is a protein with tyrosine-protein kinase activity. It can regulate the biological functions of bradykinin, coupling factor 6, and vascular endothelial growth factor through the redox effect. Thus, SRC plays a crucial part in cardiovascular and cerebrovascular diseases such as hypertension and stroke \[[@B55]\]. As members of the transcription activation factor AP-1 family, FOS (including c-Fos, FosB, Fra1, and Fra2) and JUN (including c-Jun, JunB, and JunD) can form dimers in various combinations through leucine zipper regions \[[@B56]\]. They have biological functions such as cell proliferation, differentiation, and apoptosis. It has been reported that JNK\'s antiprotease peptides can exert brain-protective functions by blocking c-Fos transcription and c-Jun activation \[[@B57]\].

Based on the KEGG enrichment analysis, musk was thought to influence some important pathways, which were highlighted to play important roles in anti-ischemic stroke. Those signaling pathways included the TNF signaling pathway, estrogen signaling pathway, prolactin signaling pathway, neurotrophin signaling pathway, T-cell receptor signaling pathway, cAMP signaling pathway, FoxO signaling pathway, and HIF-1 signaling pathway.

The pathophysiology of ischemic stroke is very complicated. And inflammation and immune response are important pathophysiological changes in the progression of ischemic stroke, which involves both innate and adaptive immune systems. After a stroke, damaged nerve cells will induce glial cell activation, peripheral immune cell infiltration, and release of inflammatory mediators. Then, the damage of the blood-brain barrier and the occurrence of cerebral edema is aggravated, causing secondary brain damage \[[@B58]\]. Lee et al. found in animal studies that musk of muskrat has a neuroprotective effect. It can reduce the volume of transient focal cerebral ischemic infarction and improve spontaneous and vestibular sensorimotor dysfunction caused by ischemia. The mechanism is related to inhibiting the expression of COX-2 and exerting an anti-inflammatory response \[[@B59]\]. TNF is an inflammatory factor produced by activating monocytes or macrophages. Existing studies reported that the expression of TNF-*α* is significantly increased in patients with acute ischemic stroke. This suggests that TNF-*α* plays a crucial part in the pathogenesis of ischemic stroke \[[@B60]\]. TNF-*α* affects blood-brain barrier permeability. It can activate glial cells and mediates the expression of adhesion molecules on vascular endothelial cells, so as to promote infiltration of neutrophils \[[@B61]\]. Consequently, selective inhibition of TNF-*α* has potential application prospects in reducing blood-brain barrier disruption and improving neurological prognosis \[[@B54]\]. Clinical trial results show that musk can reduce the level of TNF-*α* in patients with ischemic stroke and improve the effectiveness of treatment \[[@B62]\]. Moreover, in terms of adaptive immunity, T-cell receptors are specific receptors on the surface of T cells that provide a connection between T cells and antigen-presenting cells and play an important part in the immune response function of T cells. Severe brain injury, such as ischemic stroke, will rapidly activate the peripheral immune system and promote T or B lymphocytes, monocytes, and neutrophils to the destroyed area \[[@B63]\]. Although the role of adaptive immunity in neuroinflammation has not been clearly defined, studies have demonstrated that mice lacking T and B cells have a smaller infarct size than normal mice \[[@B64]\]. And, a researcher has found that selective inhibition of T-cell receptors can reduce the infarct volume and promote long-term functional recovery \[[@B65]\].

Estrogen mediates genetic effects by binding to the receptors on the nucleus or cell membrane \[[@B66]\]. In recent years, the protective effect of estrogen on ischemic stroke has received widespread attention \[[@B67]\]. Neuroprotective effects of estrogen are mainly exerted by antagonizing excitatory amino acids, antioxidant stress, dilating blood vessels, and increasing cerebral blood flow \[[@B68]\]. The active ingredient in musk, 17-*β*-estradiol, is one of the main ingredients in estrogen. Evidence showed that 17-*β*-estradiol can reduce the infarct volume and reperfusion injury after stroke and accelerates the recovery of motor and sensory functions \[[@B69]\]. Moreover, prolactin is a cofactor for platelet activation \[[@B70]\]. Hyperprolactinemia may be part of the risk factors for stroke, which mediates thrombosis by enhancing platelet reactivity \[[@B71]\]. Neurotrophins family, including nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3, play an important role in the repair of neural tissue damage. Becker holds that when cerebral ischemia occurs, brain-derived neurotrophic factor binds to the neurotrophin receptor p75 and then activates the c-JunN-terminal kinase pathway to mediate apoptosis \[[@B72]\]. In animal studies, neurotrophin-3 may promote sensory and motor function recovery after stroke \[[@B73]\]. This indicates that neurotrophin-3 has potential applications in the treatment of stroke. cAMP is the second messenger in the cell, which activates cAMP-dependent protein kinase A (PKA). cAMP/PKA signaling pathway is related to nerve regeneration. Yuan et al. found that musk acupuncture treatment can significantly promote the synthesis and release of cAMP, PKA, and pCREB in the brain tissue of ischemic stroke rats and improve the rehabilitation of motor function \[[@B74]\]. Hypoxia-inducible factor 1 (HIF-1) is a major regulator of cells adapting to the hypoxic environment. It can induce angiogenesis, which participates in many pathophysiological processes. In ischemic stroke, HIF-1-mediated angiogenesis is more mature and stable, and it is a promising measure for the treatment of ischemic stroke \[[@B75]\]. Therefore, the role of musk on the HIF-1 signal in ischemic stroke was still controversial, and experimental studies should be designed to evaluate the role of musk for ischemic stroke.

The ischemic stroke involves multiple pathological processes. Traditional Chinese medicine, musk, exerts its pharmacological effect on ischemic stroke through a "multicomponent, multitarget, multipath" effect mechanism. However, our research may have a few limitations. Further biological research is needed in order to verify the results of the above studies.

5. Conclusions {#sec5}
==============

In summary, based on the network pharmacology approach, we explored the material basis and effective mechanism of musk for ischemic stroke. Potential functional ingredients such as muscone, testosterone, 17-*β*-estradiol, and musk pyridine have been discovered in this study. These components may have a neuroprotective role after ischemic stroke by regulating various pathways such as apoptosis, inflammatory response, and gene transcription. Our study explained the improvement effect of musk for ischemic stroke theoretically and helped the development and application of musk for ischemic stroke.
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The detailed information of chemical composition and predicted target of musk (S1), ischemic stroke target (S2), string data (S3), compound target analysis data (S4), Gene Ontology enrichment analysis results (S5, S6, and S7), and KEGG enrichment analysis results (S8 and S9) used to support the findings of this study is included within the supplementary information files.
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!["Ingredient-target-pathway/disease network" of musk (the heptagon is on behalf of the musk compounds, the star node represents prediction target, the yellow circle represents the enrichment pathway, and the red and green squares represent the disease phenotype).](ECAM2020-4063180.004){#fig4}

![The core target network of musk for ischemic stroke (color and size of nodes reflected degree centrality, while the edge thickness and color\'s depth reflected the combined score).](ECAM2020-4063180.005){#fig5}

![Core network clustering diagram of musk for ischemic stroke.](ECAM2020-4063180.006){#fig6}
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![Multidimensional network of "core component-target-pathway."](ECAM2020-4063180.008){#fig8}

###### 

Active chemical constituents of musk.

  No   Compound name                             Molecular formula     Molecular weight (g/mol)   CID
  ---- ----------------------------------------- --------------------- -------------------------- ----------
  1    17-Beta-estradiol                         C~18~H~24~O~2~        272.4                      5757
  2    2, 6-Decamethylene pyridine               C~15~H~23~N           217.4                      5316410
  3    3, 5-Dihydroxybenzoic acid                C~7~H~6~O~4~          154.1                      7424
  4    3-Alpha-hydroxy-5alpha-androstan-17-one   C~19~H~30~O~2~        290.4                      5879
  5    3-Beta-hydroxy-5alpha-androstan-17-one    C~19~H~30~O~2~        290.4                      441302
  6    3-Methylcyclotridecan-1-one               C~14~H~26~O           210.4                      3017257
  7    5-cis-Cyclopentadecen-1-one               C~15~H~26~O           222.4                      5316264
  8    5-cis-Cyclotetradecen-1-one               C~14~H~24~O           208.4                      5316269
  9    Allantoin                                 C~4~H~6~N~4~O~3~      158.1                      204
  10   Alpha-estradiol                           C~18~H~24~O~2~        272.4                      6432565
  11   Androst-4-ene-3, 17-dione                 C~19~H~26~O~2~        286.4                      6128
  12   Androsterone                              C~19~H~30~O~2~        290.4                      5879
  13   Cholesterol                               C~27~H~46~O           386.7                      5997
  14   Cholesteryl ferulate                      C~37~H~54~O~4~        562.8                      22375086
  15   Cyclotetradecan-1-one                     C~14~H~26~O           210.4                      77153
  16   Cyclovirobuxine                           C~26~H~46~N~2~O       402.7                      260439
  17   Decamine                                  C~30~H~40~Cl~2~N~4~   527.6                      10649
  18   Estragole                                 C~10~H~12~O           148.2                      8815
  19   Hydroxymuscopyridine A                    C~16~H~25~NO          247.4                      184938
  20   Hydroxymuscopyridine B                    C~16~H~25~NO          247.4                      184939
  21   Morin                                     C~4~H~6~N~4~O~3~      302.2                      5281670
  22   Musclide A1                               C~8~H~18~O~5~S        226.3                      5319969
  23   Muscol                                    C~12~H~17~NO          191.3                      4284
  24   Muscone                                   C~16~H~30~O           238.4                      10947
  25   Muscopyridine                             C~16~H~25~N           231.4                      193306
  26   Musennin                                  C~51~H~82~O~21~       1031.2                     441933
  27   N-Nonane                                  C~9~H~20~             128.3                      8141
  28   Normuscone                                C~15~H~28~O           224.4                      10409
  29   Testosterone                              C~19~H~28~O~2~        288.4                      6013

###### 

GO analysis was implemented on core targets.

  Category           Term                                                                                            Count   *P* value
  ------------------ ----------------------------------------------------------------------------------------------- ------- --------------
  GOTERM BP DIRECT   GO:0045944-positive regulation of transcription from RNA polymerase II promoter                 36      4.65*E* − 21
  GOTERM BP DIRECT   GO:0045893-positive regulation of transcription, DNA-templated                                  28      2.78*E* − 20
  GOTERM BP DIRECT   GO:0007568-aging                                                                                16      5.75*E* − 15
  GOTERM BP DIRECT   GO:0042493-response to drug                                                                     19      1.64*E* − 14
  GOTERM BP DIRECT   GO:1902895-positive regulation of pri-miRNA transcription from RNA polymerase II promoter       9       4.48*E* − 14
  GOTERM BP DIRECT   GO:0010628-positive regulation of gene expression                                               17      3.44*E* − 13
  GOTERM BP DIRECT   GO:0008217-regulation of blood pressure                                                         11      1.16*E* − 12
  GOTERM BP DIRECT   GO:0001666-response to hypoxia                                                                  14      4.59*E* − 12
  GOTERM BP DIRECT   GO:0051091-positive regulation of sequence-specific DNA binding transcription factor activity   12      6.31*E* − 12
  GOTERM BP DIRECT   GO:0043066-negative regulation of the apoptotic process                                         19      1.53*E* − 11
  GOTERM MF DIRECT   GO:0008134-transcription factor binding                                                         19      4.57*E* − 15
  GOTERM MF DIRECT   GO:0019899-enzyme binding                                                                       19      7.25*E* − 14
  GOTERM MF DIRECT   GO:0042802-identical protein binding                                                            24      2.39*E* − 12
  GOTERM MF DIRECT   GO:0005515-protein binding                                                                      77      2.53*E* − 12
  GOTERM MF DIRECT   GO:0019901-protein kinase binding                                                               16      7.65*E* − 10
  GOTERM MF DIRECT   GO:0044212-transcription regulatory region DNA binding                                          13      9.23*E* − 10
  GOTERM MF DIRECT   GO:0046982-protein heterodimerization activity                                                  16      1.36*E* − 08
  GOTERM MF DIRECT   GO:0003707-steroid hormone receptor activity                                                    8       1.43*E* − 08
  GOTERM MF DIRECT   GO:0005102-receptor binding                                                                     14      2.98*E* − 08
  GOTERM MF DIRECT   GO:0000978-RNA polymerase II core promoter proximal region sequence-specific DNA binding        14      3.18*E* − 08
  GOTERM CC DIRECT   GO:0005654-nucleoplasm                                                                          39      2.19*E* − 10
  GOTERM CC DIRECT   GO:0005829-cytosol                                                                              41      2.37*E* − 09
  GOTERM CC DIRECT   GO:0043234-protein complex                                                                      15      8.82*E* − 09
  GOTERM CC DIRECT   GO:0005886-plasma membrane                                                                      45      1.05*E* − 08
  GOTERM CC DIRECT   GO:0005615-extracellular space                                                                  25      1.06*E* − 08
  GOTERM CC DIRECT   GO:0005576-extracellular region                                                                 27      1.66*E* − 08
  GOTERM CC DIRECT   GO:0005901-caveola                                                                              8       2.46*E* − 08
  GOTERM CC DIRECT   GO:0000790-nuclear chromatin                                                                    11      2.77*E* − 08
  GOTERM CC DIRECT   GO:0043005-neuron projection                                                                    11      1.91*E* − 07
  GOTERM CC DIRECT   GO:0005634-nucleus                                                                              46      1.36*E* − 05

###### 

KEGG enrichment analysis was performed on core targets.

  Category       Term                                                 Count   *P* value
  -------------- ---------------------------------------------------- ------- --------------
  KEGG PATHWAY   hsa04668: TNF signaling pathway                      18      3.55*E* − 15
  KEGG PATHWAY   hsa04915: estrogen signaling pathway                 17      1.87*E* − 14
  KEGG PATHWAY   hsa04917: prolactin signaling pathway                14      1.23*E* − 12
  KEGG PATHWAY   hsa04722: neurotrophin signaling pathway             16      6.49*E* − 12
  KEGG PATHWAY   hsa04660: T-cell receptor signaling pathway          15      7.24*E* − 12
  KEGG PATHWAY   hsa04024: cAMP signaling pathway                     19      9.88*E* − 12
  KEGG PATHWAY   hsa04068: FoxO signaling pathway                     16      3.29*E* − 11
  KEGG PATHWAY   hsa04066: HIF-1 signaling pathway                    14      6.72*E* − 11
  KEGG PATHWAY   hsa04932: nonalcoholic fatty liver disease (NAFLD)   15      2.01*E* − 09
  KEGG PATHWAY   hsa04015: Rap1 signaling pathway                     17      2.26*E* − 09
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